Related Experiment Videos
Identification of progressive glaucomatous visual field loss
Paul G D Spry1, Chris A Johnson
1Bristol Eye Hospital, Bristol, United Kingdom.
Survey of Ophthalmology
|March 29, 2002
Summary
Detecting glaucoma progression is challenging due to visual field test variability. Current methods have pros and cons, with combined clinical judgment and successive examinations being most reliable for identifying true visual field loss.
Area of Science:
- Ophthalmology
- Visual Science
- Medical Statistics
Background:
- Visual field measures in healthy individuals show variability.
- Glaucoma significantly increases physiologic variability, complicating the detection of true visual function loss.
- Distinguishing progressive glaucomatous visual field loss from test variability is a complex clinical challenge.
Purpose of the Study:
- To review and categorize existing methods for detecting glaucomatous visual field progression.
- To discuss the benefits and drawbacks of each method.
- To provide insight into the current best practices and future directions for progression detection.
Main Methods:
- Categorization of progression detection procedures into four groups: clinical judgment, defect classification systems, trend analyses, and event analyses.
- Review of the principles and applications of each category, including examples like the Advanced Glaucoma Intervention Study scoring system and linear regression.
- Discussion of the advantages and limitations inherent in each approach.
Main Results:
- No single method for detecting glaucomatous visual field progression is universally ideal.
- Each of the four reviewed methods (clinical judgment, defect classification, trend analysis, event analysis) has specific benefits and drawbacks.
- Current best practice involves confirming changes across successive examinations and correlating visual field changes with other clinical observations.
Conclusions:
- The detection of progressive glaucomatous visual field loss requires careful consideration of test variability.
- A combination of methods, emphasizing confirmation over time and clinical correlation, is currently the most effective strategy.
- Advancements in analysis methods are anticipated to improve future detection of progressive loss.